[The time for gold therapy has not yet expired].
Schattenkirchner
M
M
D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D006801:Humans; D050607:Organogold Compounds; D016896:Treatment Outcome
D018501:Antirheumatic Agents; D050607:Organogold Compounds